522 related articles for article (PubMed ID: 17145185)
1. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer.
Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
Eur J Cardiothorac Surg; 2007 Feb; 31(2):154-60. PubMed ID: 17145185
[TBL] [Abstract][Full Text] [Related]
2. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
3. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
4. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
Zhang GQ; Han F; Sun W; Pang ZL; SiKanDaer AB; Wang HJ
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):858-62. PubMed ID: 19173833
[TBL] [Abstract][Full Text] [Related]
5. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
[TBL] [Abstract][Full Text] [Related]
6. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
7. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection.
Kato H; Tachimori Y; Watanabe H; Igaki H; Nakanishi Y; Ochiai A
J Surg Oncol; 1996 Apr; 61(4):267-72. PubMed ID: 8627996
[TBL] [Abstract][Full Text] [Related]
8. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
9. Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy.
Fujita H; Sueyoshi S; Tanaka T; Fujii T; Toh U; Mine T; Sasahara H; Sudo T; Matono S; Yamana H; Shirouzu K
World J Surg; 2003 May; 27(5):571-9. PubMed ID: 12715226
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
11. [Selective three-field lymphadenectomy for thoracic esophageal squamous carcinoma].
Fang WT; Chen WH; Chen Y; Shen YZ; Jiang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Sep; 9(5):388-91. PubMed ID: 17043956
[TBL] [Abstract][Full Text] [Related]
12. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
13. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy?
D'Journo XB; Doddoli C; Michelet P; Loundou A; Trousse D; Giudicelli R; Fuentes PA; Thomas PA
Eur J Cardiothorac Surg; 2005 Apr; 27(4):697-704. PubMed ID: 15784377
[TBL] [Abstract][Full Text] [Related]
14. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
15. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
Mariette C; Piessen G; Briez N; Triboulet JP
Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
17. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Zheng X; Zhu K; Li J; Chen M; Wang J; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):475-82. PubMed ID: 20934269
[TBL] [Abstract][Full Text] [Related]
18. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
[TBL] [Abstract][Full Text] [Related]
19. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
20. An audit of surgical outcomes of esophageal squamous cell carcinoma.
Goan YG; Chang HC; Hsu HK; Chou YP
Eur J Cardiothorac Surg; 2007 Mar; 31(3):536-44. PubMed ID: 17222561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]